Professional Documents
Culture Documents
BUSINESS
IDEAS AT WORK
SPARKLING
INNOVATION
GlaxoSmithKline faced a
situation common to large
global organisations: how to
allocate marketing resources to
smaller, regional brands. Julian
Birkinshaw and Peter Robbins
report on the company’s inventive
approach to worldwide marketing
that led to the development of a
unique and productive network.
Focus and simplification are very
much in vogue in many of the
world’s biggest consumer products
companies. For example, Procter &
Gamble’s concentration on its largest
brands, largest customers and largest
markets since 2000 has been a major
driver of growth, and Unilever has
embarked on a similar strategy of
focusing on its top 50 brands.
But focus brings inevitable
challenges as well. What happens
to the products that don’t make
GSK: PUTTING THE FIZZ INTO REGIONAL BRANDS
the cut? Do you sell them off? Do
you run them as cash cows? Or do
you encourage your teams to grow lower-priority brands continued to
them without corporate support? develop, it created a community The Spark Network
And what about the marketing and of marketing and research and
development (R&D) people around
was intended to light
research personnel who aren’t in the
focal group: do you encourage them the world that came to be known as up the company with
to move on, or do you continue the Spark Network; it used the word new ideas and become
to look for ways to motivate and ‘spark’ because it was intended to light
engage them? These are tricky up the company with new ideas and a hotbed of creativity
strategic challenges, and they require become a hotbed of creativity for the for the business.
thoughtful managerial responses. business. The network has become a
GlaxoSmithKline (GSK) valuable source of new ideas as well
Consumer Healthcare is a fascinating as a learning and support system
case in point. To ensure that its for its members. But how do you
GLAXOSMITHKLINE HOUSE
sustain and institutionalise a network a more centralised, robust and global plans and strategic initiatives
deliberately designed to be informal connected global marketing and — and local activation of those plans
and virtual in nature? R&D organisation for our global and programmes. The role of the
brands — freeing-up our regional and local marketer is very important in
Demanding challenges local brands — by essentially putting activation, because, naturally, the
GSK is indeed a large organisation, decision making in the right places plans have no value unless they
and GSK Consumer Healthcare is a and at the right levels.” are executed with professionalism,
major business unit within it — almost The Future Group was split ambition and excellence.
£4 billion in revenues. The unit sells between the UK, near London, “With the Future Group we got
well-known consumer brands such and New Jersey in the US. People a coalition of excellent, experienced
as Lucozade, Aquafresh, Sensodyne, were selected from around the and talented people working closely
Panadol and Horlicks, as well as world to staff the group, with together and leveraging their ideas
increasing numbers of over-the- experts in strategy development, globally,” said a GSK manager.
counter medicines. The business advertising development, new “And, although the markets are
involves substantial R&D investment product development and R&D. In centrally involved, some of them felt
and faces stringent regulatory approval total around 150 people across the that they now had less of a voice in
processes. It also has additional company’s top seven brands were the big decisions. Most people join
challenges, including demanding brought together. The Future Group our marketing teams out of a sense
consumers, highly consolidated retail focused on global brand innovation of personal, commercial creativity,
channels and short cycle times for and brand equity, while the individual but a lot of consumer marketing
new product development. country marketing teams retained full in all large companies is now very
In 2004, the executives running responsibility for local deployment. mechanical, linear and logical and
consumer health care decided to This new centralised model led to uses standard processes. For both
centralise marketing and R&D for its some rapid improvements, with these reasons, we felt a growing
big global brands, such as Lucozade growth up from three per cent in need for some forum by which the
and Aquafresh, into the Future 2007 to 12% in 2008. creativity of our people could be
Group. Tim Wright, now head of productively harnessed.”
the Future Group, recalled, “The The right balance There were many highly successful,
problem was we were not growing fast With the creation of the Future fast-growing brands at stake —
enough. We challenged three teams to Group, the company needed to strike Solpadeine and Ribena in the UK
determine how to accelerate growth in exactly the right balance between and Ireland, Tums in North America,
the company, and they recommended the central creation of big brands, Contac in Asia, Horlicks in India.